NO20044131L - Jerndekstrinforbindelser for behandling av jernmangelanemi - Google Patents

Jerndekstrinforbindelser for behandling av jernmangelanemi

Info

Publication number
NO20044131L
NO20044131L NO20044131A NO20044131A NO20044131L NO 20044131 L NO20044131 L NO 20044131L NO 20044131 A NO20044131 A NO 20044131A NO 20044131 A NO20044131 A NO 20044131A NO 20044131 L NO20044131 L NO 20044131L
Authority
NO
Norway
Prior art keywords
molecular weight
iron
daltons
treatment
average molecular
Prior art date
Application number
NO20044131A
Other languages
English (en)
Norwegian (no)
Inventor
Hans Berg Andreasen
Lars Christensen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of NO20044131L publication Critical patent/NO20044131L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20044131A 2002-04-09 2004-09-29 Jerndekstrinforbindelser for behandling av jernmangelanemi NO20044131L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200512 2002-04-09
PCT/DK2003/000228 WO2003087164A1 (en) 2002-04-09 2003-04-08 Iron dextrin compounds for the treatment of iron deficiency anaemia

Publications (1)

Publication Number Publication Date
NO20044131L true NO20044131L (no) 2004-09-29

Family

ID=28459423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044131A NO20044131L (no) 2002-04-09 2004-09-29 Jerndekstrinforbindelser for behandling av jernmangelanemi

Country Status (23)

Country Link
US (1) US20030191090A1 (de)
EP (1) EP1492821B1 (de)
JP (1) JP4520748B2 (de)
KR (1) KR20040104560A (de)
CN (1) CN1309741C (de)
AR (1) AR039396A1 (de)
AT (1) ATE335008T1 (de)
AU (1) AU2003226923B2 (de)
BR (1) BR0308773A (de)
CA (1) CA2480365A1 (de)
DE (1) DE60307249T2 (de)
DK (1) DK1492821T3 (de)
EA (1) EA006720B1 (de)
ES (1) ES2270070T3 (de)
MX (1) MXPA04009770A (de)
NO (1) NO20044131L (de)
NZ (1) NZ535761A (de)
PL (1) PL373403A1 (de)
PT (1) PT1492821E (de)
SI (1) SI1492821T1 (de)
UA (1) UA79452C2 (de)
WO (1) WO2003087164A1 (de)
ZA (1) ZA200407658B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
WO2005087216A2 (de) * 2004-03-12 2005-09-22 Eberhard-Karls-Universität Tübingen Behandlung von anämischen zuständen durch inhibierung der erythrozytenapoptose
JP4550543B2 (ja) * 2004-10-07 2010-09-22 松谷化学工業株式会社 鉄、マグネシウム又は亜鉛成分に対する食品用マスキング剤
MX2007009588A (es) 2005-02-09 2007-09-12 Vifor Int Ag Uso de compuestos de complejo de hierro(iii).
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
BRPI0924653B8 (pt) * 2009-03-25 2021-05-25 Pharmacosmos Holding As composto de ferro-oligossacarídeo, composição e uso de deste composto
CN106176808A (zh) * 2010-10-19 2016-12-07 长春纳米生技公司 金属离子纳米簇组合物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
JP6189309B2 (ja) * 2011-10-13 2017-08-30 ヴィダシム・インコーポレーテッド 鉄−繊維組成物、その調製および使用
EP2983527B1 (de) 2013-03-08 2019-04-24 Vidasym, Inc. Komplexe zusammensetzungen aus metallionen und funktionellen faserkomponenten, herstellung und verwendungen
EP2997968A1 (de) 2014-09-22 2016-03-23 Ioulia Tseti Eisen-(III)-Hydroxidkomplexe mit aktivierten Glucosesirups und Verfahren zur Herstellung davon
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
WO2018198135A1 (en) * 2017-04-26 2018-11-01 Mylan Laboratories Ltd. Improved process for the preparation of iron complex
CN107519198A (zh) * 2017-07-21 2017-12-29 南通市第人民医院 一种右旋糖酐铁注射液及其制备方法
EP3932535A1 (de) 2020-07-01 2022-01-05 Vifor Fresenius Medical Care Renal Pharma, Ltd. Verfahren zur herstellung von durch kohlenhydrate und/oder huminsäure stabilisierten mehrkernigen eisenverbindungen
AU2022323733A1 (en) * 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) * 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
ES360433A1 (es) * 1968-11-20 1970-11-16 Rocador Sa Procedimiento para la fabricacion de un compuesto de hierrotrivalente apropiado para administracion por via oral.
US3686397A (en) * 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
JPS6128502A (ja) * 1985-04-06 1986-02-08 Nippon Zoki Pharmaceut Co Ltd デキストリン・ヒドロキシカルボン酸・第二鉄多核複合体の製造方法
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Also Published As

Publication number Publication date
SI1492821T1 (sl) 2006-12-31
ATE335008T1 (de) 2006-08-15
EP1492821A1 (de) 2005-01-05
CN1646568A (zh) 2005-07-27
ZA200407658B (en) 2006-07-26
EA006720B1 (ru) 2006-04-28
CN1309741C (zh) 2007-04-11
PT1492821E (pt) 2006-12-29
DE60307249D1 (de) 2006-09-14
HK1069589A1 (en) 2005-05-27
AU2003226923A1 (en) 2003-10-27
KR20040104560A (ko) 2004-12-10
JP4520748B2 (ja) 2010-08-11
AU2003226923B2 (en) 2006-08-17
ES2270070T3 (es) 2007-04-01
WO2003087164A1 (en) 2003-10-23
EP1492821B1 (de) 2006-08-02
DK1492821T3 (da) 2006-11-27
DE60307249T2 (de) 2007-03-15
AR039396A1 (es) 2005-02-16
MXPA04009770A (es) 2004-12-13
JP2005530863A (ja) 2005-10-13
US20030191090A1 (en) 2003-10-09
NZ535761A (en) 2007-09-28
BR0308773A (pt) 2005-02-09
CA2480365A1 (en) 2003-10-23
EA200401330A1 (ru) 2005-02-24
UA79452C2 (en) 2007-06-25
PL373403A1 (en) 2005-08-22

Similar Documents

Publication Publication Date Title
MX2009005495A (es) Agentes de revestimiento que tienen elevada resistencia al rasguño y estabilidad en la intemperie.
EP1551834A4 (de) Substituierte quinazolinone verbindungen
ATE527978T1 (de) Orale zinnzusammensetzungen
CA2334534A1 (en) Dental restoratives
NO20161348A1 (no) Anvendelse av 40-O-(2-hydroksyetyl)-rapamycin i behandling av faste tumorer i lunger annet enn lymfekreft
TW200643047A (en) Ethylene/α-olefins block interpolymers
YU5003A (sh) Nova farmaceutska smeša
BR0308773A (pt) Compostos de dextrina de ferro para tratamento de anemia por deficiência de ferro
EP2684554A3 (de) Verwendung von Keramik in dental- und kieferorthopädischen Anwendungen
DK1181038T3 (da) Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer
DE50207744D1 (de) Pfropfpolymerisate mit stickstoffheterocyclen enthaltenden seitenketten
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
WO2004108093A3 (en) Antiseptic compositions, methods and systems
DK1409708T3 (da) Anvendelser af en glucan afledt af mælkesyrebakterier som anti-korrosionsmiddel
WO2005019241A3 (en) Cationic antimicrobial peptides and compositions thereof
EP1908759A3 (de) 3,4-Dihydro-3-amino-2H-1-benzopyran und -benzothiopyran Derivate als Dopamine-beta-hydroxylase Inhibitoren und Verfahren zu ihrer Herstellung
GB0123572D0 (en) Polymer compositions
WO2001092309A3 (en) Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
MXPA05005854A (es) Utilizacion de polisacaridos particulares como mezclas de materiales minerales.
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
DE69833937D1 (de) Verwendung von zinkhyaluronat gegen magengeschwür
NO20064142L (no) Nedbrytningshemmer
NO20012055L (no) Kombinasjon av assosiative fortykningsmidler og vandige beskyttende beleggsammensetninger
MX2007004807A (es) Composiciones para el cuidado del cabello.
DK1910425T3 (da) Fotopolymeriserbare systemer, der indeholder co-initiatorer med lav ekstraherbarhed og flygtighed

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application